Stocktoria

ALUMIS INC. ALMS

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-06-28
Chart by TradingView
1/9
Piotroski F — financial health
-7.78
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023
Financials
Revenue$24.1M
Operating income-$453.8M-$300.8M-$158.2M
Net income-$243.3M-$294.2M-$155.0M
Operating cash flow-$369.5M-$255.1M-$130.0M
Free cash flow-$370.2M-$256.8M-$134.5M
Total assets$411.9M$341.0M$89.6M
Total liabilities$110.6M$80.9M$53.5M
Shareholders' equity$301.3M$260.1M-$339.3M
Ratios
Operating margin-1886.9%
Net margin-1011.7%
FCF margin-1539.2%
Return on assets-59.1%-86.3%-173.0%
Return on equity-80.8%-113.1%45.7%
Current ratio4.346.012.56

Notable holders (13F)

InvestorSharesValue
Point72 Asset Management, L.P.382,585$8.4M
RENAISSANCE TECHNOLOGIES LLC75,167$1.7M

Why these scores methodology →

Piotroski F-score: 1/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -7.78 (distress)

  • Working capital / assets 0.595
  • Retained earnings / assets -2.189
  • EBIT / assets -1.102
  • Equity / liabilities 2.723

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001847367 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.